<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="15974" whole_study_id="15974" phs="000984" v="1" p="1" createDate="2015-07-10T11:47:04-05:00" completedByGPADate="2015-07-24T16:21:38-05:00" modDate="2019-05-08T10:31:34-05:00" maxParentChildStudyModDate="2019-05-08T10:31:34-05:00" handle="Metformin_T2DM" num_participants="500"><StudyInfo accession="phs000984.v1.p1" parentAccession="phs000984.v1.p1"><BioProject id="PRJNA294475" entrez_id="294475" type="bp_admin_access"/><BioProject id="PRJNA294476" entrez_id="294476" type="bp_data_submission"/><StudyNameEntrez>Pharmacogenomics of metformin dose response in T2DM patients</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>metagenomic</StudyType><StudyType>dna</StudyType><StudyType>array_derived_genotypes</StudyType><StudyType>whole_exome</StudyType></StudyTypes><Funding>U01 HG004609</Funding></StudyInfo><Authority><ICs><IC id="1" name="NIGMS" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="RCHISHOLM" aid="2" auth="eRA" login="RCHISHOLM" fname="Rex" mname="L" lname="Chisholm" email="r-chisholm@northwestern.edu"><Role>PI</Role><Organization>NORTHWESTERN UNIVERSITY AT CHICAGO</Organization></Person><Person aid="8" auth="virtual" fname="Jennifer" lname="Pacheco" email="japacheco@northwestern.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010150228" aid="1" auth="cit" login="dkras" fname="Donna" mname="M" lname="Krasnewich-Vostal" email="dkras@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="6 months"><acknowledgement_statement>The project was supported by the Pharmacogenomics Research Network (PGRN). The datasets used for the analyses were extracted from the Northwestern Medicine Enterprise Data Warehouse which was supported, in part, by the Northwestern University Clinical and Translational Science Institute, Grant Number UL1TR000150 from the National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (CTSA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The CTSA is a registered trademark of the U.S. Department of Health and Human Services (DHHS). Samples for analysis were provided by the NUgene Project at Northwestern University, with support from Northwestern Medicine and were genotyped by The Feinstein Institute for Medical Research. The algorithm used for identifying T2DM subjects in the electronic health record is described in the following article: Kho AN, Hayes MG, Rasmussen-Torvik L, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc. 2012 Mar-Apr;19(2):212-8. Epub 2011 Nov 19. PMID: 22101970. Phenotyping was supported by grants from the National Human Genome Research Institute, eMERGE I and II, Grant Numbers 1U01HG004609-01 and 1U01HG006388-01.  Genotyping for this study was supported by the National Institute of General Medical Sciences, Grant Number U19GM061390. </acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="1660" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="58" dac_name="NIGMS" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

May be used for genetic studies to learn about, prevent, or treat health problems. 
No Insurance companies may be allowed to use this data.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>